CYTR

CytRx Corporation News Headlines

$3.23
*  
0.10
3%
Get CYTR Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading CYTR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
CytRx Candidate Encourages in Soft Tissue Sarcoma Study - Analyst Blog
1/26/2015 4:45:00 AM - Investopedia


Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinical Hold Lifted - Analyst Blog
1/21/2015 11:02:00 AM - Investopedia


Advaxis: Heavily Promoted And Misleading Investors
1/21/2015 10:24:00 AM - Seeking Alpha


Advaxis: Heavily Promoted And Misleading Investors
1/21/2015 9:30:00 AM - Seeking Alpha


CytRx Relieved as FDA Lifts Partial Hold on Oncology Drug - Analyst Blog
1/21/2015 4:15:00 AM - Investopedia


CytRx : FDA Removes Partial Clinical Hold For Aldoxorubicin Trials
1/20/2015 6:52:00 AM - RTT News


What's To Like About CytRx's Brain Cancer Data?
1/20/2015 3:37:00 AM - Seeking Alpha


FOLD Unfolds, No Pain, All Gain For NBIX, VSAR Picks Up Velocity, RVNC On Watch
1/9/2015 1:16:00 AM - RTT News


CytRx Jumps on Positive Results from Brain Cancer Study - Analyst Blog
1/7/2015 2:16:00 PM - Investopedia


ALKS Moves Forward, KBIO Craters, GILD Opens Wallet, TRVN For The Long Haul
1/7/2015 2:13:00 AM - RTT News


FDA Sends Notice To CytRx After Placing Cancer Drug Trials On Partial Hold
12/3/2014 6:31:00 AM - RTT News


More Fallout From Stock Promotion Scandal
11/14/2014 2:35:00 PM - Seeking Alpha


3 Lessons From The Galena Scandal
8/22/2014 6:56:00 AM - Seeking Alpha


Three Lessons From The Galena Scandal
8/21/2014 12:56:00 PM - Seeking Alpha


Three Lessons From The Galena Scandal
8/21/2014 11:02:00 AM - Seeking Alpha


RXi Pharmaceuticals: Early-Stage Biotech With A Promising Future
8/4/2014 5:22:00 PM - Seeking Alpha


Celldex: The Race Leader In Glioblastoma Multiforme
5/29/2014 3:17:00 PM - Seeking Alpha


Behind The Scenes With Proactive, Inovio And Unilife
3/27/2014 9:45:00 AM - Seeking Alpha


CytRx's Aldoxorubicin's Potential Is Underestimated, Creating A Buying Opportunity
2/7/2014 9:06:00 AM - Seeking Alpha


Spotlight 2014-Biotech CytRx Corporation
1/17/2014 9:03:00 AM - Seeking Alpha


Progenics Likely To Announce Positive Prostate Cancer Data In January
1/7/2014 8:00:00 AM - Seeking Alpha


Bristol-Myers Squibb Vs. Roche In The Brain Cancer Race
1/2/2014 8:58:00 AM - Seeking Alpha


CytRx Corporation Poised For Success In 2014
12/31/2013 2:12:00 AM - Seeking Alpha


CytRx Surges As Aldoxorubicin Dominates Doxorubicin In Phase IIB Tests
12/12/2013 12:28:00 PM - Seeking Alpha


CytRx Surges Ahead With Positive Drug Data
11/1/2013 7:41:00 AM - Seeking Alpha